IBDEI33O ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,49513,1,3,0)
 ;;=3^NHL NEC,Extranodal & Solid Organ
 ;;^UTILITY(U,$J,358.3,49513,1,4,0)
 ;;=4^C85.89
 ;;^UTILITY(U,$J,358.3,49513,2)
 ;;=^5001730
 ;;^UTILITY(U,$J,358.3,49514,0)
 ;;=C79.51^^191^2467^33
 ;;^UTILITY(U,$J,358.3,49514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49514,1,3,0)
 ;;=3^Secondary Malig Neop Bone
 ;;^UTILITY(U,$J,358.3,49514,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,49514,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,49515,0)
 ;;=C79.52^^191^2467^32
 ;;^UTILITY(U,$J,358.3,49515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49515,1,3,0)
 ;;=3^Secondary Malig Neop  Bone Marrow
 ;;^UTILITY(U,$J,358.3,49515,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,49515,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,49516,0)
 ;;=C92.00^^191^2467^26
 ;;^UTILITY(U,$J,358.3,49516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49516,1,3,0)
 ;;=3^Myelobl Leuk,Acute,No Remiss
 ;;^UTILITY(U,$J,358.3,49516,1,4,0)
 ;;=4^C92.00
 ;;^UTILITY(U,$J,358.3,49516,2)
 ;;=^5001789
 ;;^UTILITY(U,$J,358.3,49517,0)
 ;;=C92.40^^191^2467^31
 ;;^UTILITY(U,$J,358.3,49517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49517,1,3,0)
 ;;=3^Promyelocyt Leuk,Acute,No Remiss
 ;;^UTILITY(U,$J,358.3,49517,1,4,0)
 ;;=4^C92.40
 ;;^UTILITY(U,$J,358.3,49517,2)
 ;;=^5001801
 ;;^UTILITY(U,$J,358.3,49518,0)
 ;;=C92.50^^191^2467^28
 ;;^UTILITY(U,$J,358.3,49518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49518,1,3,0)
 ;;=3^Myelomonocyt Leuk,Acute,No Remiss
 ;;^UTILITY(U,$J,358.3,49518,1,4,0)
 ;;=4^C92.50
 ;;^UTILITY(U,$J,358.3,49518,2)
 ;;=^5001804
 ;;^UTILITY(U,$J,358.3,49519,0)
 ;;=C78.7^^191^2467^37
 ;;^UTILITY(U,$J,358.3,49519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49519,1,3,0)
 ;;=3^Secondary Malig Neop Liver & Intrahep BD
 ;;^UTILITY(U,$J,358.3,49519,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,49519,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,49520,0)
 ;;=C91.10^^191^2467^5
 ;;^UTILITY(U,$J,358.3,49520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49520,1,3,0)
 ;;=3^Lymphocyt Leuk B-Cell,Chr,No Remiss
 ;;^UTILITY(U,$J,358.3,49520,1,4,0)
 ;;=4^C91.10
 ;;^UTILITY(U,$J,358.3,49520,2)
 ;;=^5001765
 ;;^UTILITY(U,$J,358.3,49521,0)
 ;;=D46.9^^191^2467^27
 ;;^UTILITY(U,$J,358.3,49521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49521,1,3,0)
 ;;=3^Myelodysplastic Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,49521,1,4,0)
 ;;=4^D46.9
 ;;^UTILITY(U,$J,358.3,49521,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,49522,0)
 ;;=C79.31^^191^2467^34
 ;;^UTILITY(U,$J,358.3,49522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49522,1,3,0)
 ;;=3^Secondary Malig Neop Brain
 ;;^UTILITY(U,$J,358.3,49522,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,49522,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,49523,0)
 ;;=C79.32^^191^2467^35
 ;;^UTILITY(U,$J,358.3,49523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49523,1,3,0)
 ;;=3^Secondary Malig Neop Cerebral Meninges
 ;;^UTILITY(U,$J,358.3,49523,1,4,0)
 ;;=4^C79.32
 ;;^UTILITY(U,$J,358.3,49523,2)
 ;;=^5001348
 ;;^UTILITY(U,$J,358.3,49524,0)
 ;;=G89.3^^191^2467^30
 ;;^UTILITY(U,$J,358.3,49524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49524,1,3,0)
 ;;=3^Neoplasm Related Pain
 ;;^UTILITY(U,$J,358.3,49524,1,4,0)
 ;;=4^G89.3
 ;;^UTILITY(U,$J,358.3,49524,2)
 ;;=^5004159
 ;;^UTILITY(U,$J,358.3,49525,0)
 ;;=C79.82^^191^2467^36
 ;;^UTILITY(U,$J,358.3,49525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,49525,1,3,0)
 ;;=3^Secondary Malig Neop Genital Organs
